Gene expression of the catabolic gene ADAMTS5 was significantly lower in the 100 ng/ml rhBMP-7-treated NPC pellets compared with the 10 ng/ml rhBMP-7-treated NPC pellets at day 28. This evidence concerns the gene ADAMTS5 and nasopharyngeal carcinoma.